These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1311474)

  • 1. Adenovirus infection in a renal transplant patient.
    Blohmé I; Nyberg G; Jeansson S; Svalander C
    Transplant Proc; 1992 Feb; 24(1):295. PubMed ID: 1311474
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus prophylaxis in pediatric renal transplant recipients.
    So S; Mayo C; McCullough C; Jendrisak M; Woodle S; Marsh W; Bailey T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1414-5. PubMed ID: 8382865
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double infection with fatal outcome due to cytomegalovirus and adenovirus type 3 in a premature infant].
    Peller P; Goetz O
    Z Kinderheilkd; 1971; 109(3):228-36. PubMed ID: 4323060
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenovirus infection of a renal allograft.
    Asim M; Chong-Lopez A; Nickeleit V
    Am J Kidney Dis; 2003 Mar; 41(3):696-701. PubMed ID: 12612996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
    Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
    Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
    Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMV infection after kidney transplantation in children.
    Lehnert A; Niaudet P; Broyer M
    Transplant Proc; 1996 Oct; 28(5):2805. PubMed ID: 8908068
    [No Abstract]   [Full Text] [Related]  

  • 9. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
    Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
    Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients.
    Israni A; Krok K; Cohen D; Blumberg E; Bloom RD
    Transplant Proc; 2004 Dec; 36(10):3019-24. PubMed ID: 15686685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do we know about adenovirus in renal transplantation?
    Florescu MC; Miles CD; Florescu DF
    Nephrol Dial Transplant; 2013 Aug; 28(8):2003-10. PubMed ID: 23493328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients.
    Lautenschlager I; Höckerstedt K; Salmela K
    Transplant Proc; 1994 Jun; 26(3):1719-20. PubMed ID: 8030100
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of cytomegalovirus infections with gancyclovir during OKT3 administration.
    Haberal M; Velidedoğlu E; Arslan G; Bilgin N; Büyükpamukçu N; Karamehmetoğlu M
    Transplant Proc; 1995 Oct; 27(5):2707. PubMed ID: 7482883
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for an immunosuppressive activity of ganciclovir.
    Scholz D; Arndt R; Meyer T
    Transplant Proc; 1994 Dec; 26(6):3253-4. PubMed ID: 7998132
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of cytomegalovirus infection in high-risk recipients after renal transplantation: prophylaxis by hyperimmunoglobulins or DHPG treatment?
    Tenschert W; Gonnermann D; Meyer-Moldenhauer WH; Cremaschi L; Huland H
    Transplant Proc; 1993 Dec; 25(6):3256-8. PubMed ID: 8266533
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytomegalovirus infection in lung transplantation; current status, detection, prophylactic treatment].
    Aoe M; Tao H; Yamane M; Toyooka S; Sano Y; Okazaki M; Date H
    Kyobu Geka; 2007 Oct; 60(11):988-92. PubMed ID: 17926902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus infections in pediatric small bowel transplant recipients.
    Florescu DF; Islam MK; Mercer DF; Grant W; Langnas AN; Freifeld AG; Sudan D; Basappa R; Dimaio D; Kalil AC
    Transplantation; 2010 Jul; 90(2):198-204. PubMed ID: 20467354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Pavlopoulou ID; Syriopoulou VP; Chelioti H; Daikos GL; Stamatiades D; Kostakis A; Boletis JN
    Clin Microbiol Infect; 2005 Sep; 11(9):736-43. PubMed ID: 16104989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.